Skip to main content
OpenTrials

Clinical trial condition

Neovascular Age-related Macular Degeneration

Explore clinical trials studying Neovascular Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.

148 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Neovascular Age-related Macular Degeneration trial results

Completed

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

NCT03386474

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Novartis Investigative Site Peoria, Arizona, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Arcadia, California, United States
  • Novartis Investigative Site Huntington Beach, California, United States
View all 65 locations
View Trial Details
Completed

Safety and Tolerability Study for Age-Related Macular Degeneration

NCT01485588

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Rocky Mountain Eye Center, P.C. Missoula, Montana, United States
  • Retina & Vitreous Center of Southern Oregon, P.C. Ashland, Oregon, United States
  • Palmetto Retina Center West Columbia, South Carolina, United States
  • Retina Research Center Austin, Texas, United States
View Trial Details
Completed

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

NCT03034772

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +3 more
Locations
  • Palo Alto Medical Foundation Palo Alto, California, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
  • Associated Retinal Consultants Royal Oak, Michigan, United States
  • Mid Atlantic Retina- Wills Eye Institute Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

NCT03249740

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more
Locations
  • Retinal Consultants of Arizona Gilbert, Arizona, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Midwest Eye Institute Indianapolis, Indiana, United States
  • Ophthalmic Consultants of Long Island Lynbrook, New York, United States
View Trial Details
Completed

Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)

NCT01775124

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +10 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Lanzhou, Gansu, China
View all 23 locations
View Trial Details

Related conditions